Valuation: Norda ASA

Market Cap 513M 53.25M 46.53M 42.94M 39.58M 74.6M 5.13B 76.25M 513M 202M 2.51B 200M 196M 8.65B P/E 2023 *
-
P/E 2024 3.26x
Enterprise Value 264M 27.43M 23.97M 22.12M 20.39M 38.43M 2.64B 39.28M 264M 104M 1.29B 103M 101M 4.45B EV / Sales 2023
-1.24x
EV / Sales 2024 0.4x
Free-Float
6.26%
Yield 2023 *
-
Yield 2024 32.5%
Manager TitleAgeSince
Chief Executive Officer - 08/04/2013
Director TitleAgeSince
Chairman 54 31/01/2014
Director/Board Member 68 20/06/2013
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%-6.12% - - 46M
-1.29%-3.11%-0.35%+3.09% 49.18B
+3.90%-0.39%+386.06%+593.85% 39.58B
-1.70%+4.46%+5.93%+60.25% 34.69B
-2.01%-0.76%+28.41%-8.01% 34.42B
+0.06%+0.34%+2.38%+34.38% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+72.42%+115.55% 15.36B
+1.12%+1.91%+14.54%+19.16% 14.05B
0.00%+1.36%+18.43%-30.79% 13.02B
Average +0.39%+0.03%+65.98%+98.43% 27.07B
Weighted average by Cap. -0.05%-0.18%+79.44%+123.32%

Financials

2023 2024
Net sales 86.92M 9.02M 7.88M 7.27M 6.7M 12.64M 869M 12.92M 86.93M 34.19M 425M 33.87M 33.13M 1.46B 372M 38.58M 33.72M 31.11M 28.68M 54.06M 3.72B 55.26M 372M 146M 1.82B 145M 142M 6.26B
Net income 31.17M 3.23M 2.83M 2.61M 2.4M 4.53M 311M 4.63M 31.18M 12.26M 153M 12.15M 11.88M 525M 126M 13.07M 11.42M 10.54M 9.71M 18.31M 1.26B 18.71M 126M 49.54M 616M 49.08M 48M 2.12B
Net Debt -311M -32.29M -28.22M -26.04M -24M -45.24M -3.11B -46.25M -311M -122M -1.52B -121M -119M -5.24B -249M -25.82M -22.56M -20.82M -19.19M -36.17M -2.49B -36.97M -249M -97.88M -1.22B -96.96M -94.83M -4.19B
Logo Norda ASA
Norda ASA, formerly NorDiag ASA, is a Norway-based company active within the biotechnology sector. It develops, manufactures and markets automated solutions (instruments and tests) for sample preparation of bacterial and human DNA from difficult biological samples for use in the fields of infectious diseases, transplantation testing (HLA Typing) and others. The Company’s products include NorDiag Arrow (CE, IVD), which is a compact, automated solution for nucleic acid extractions, as well as NorDiag Bullet, 8 tip config, which is a fully automated sample preparation instrument for molecular diagnostics and can isolate from samples such as urine, swab, faces, sputum and blood. Its distribution products include Molzym GmbH and Co KG, as well as Hain Lifescience GmbH. Its customers are clinical laboratories, hospitals, research institutes, medical diagnostics and healthcare providers. It is operational through offices and laboratories in Norway, Sweden, Austria and the United States.
Employees
-